Similar articles for PMID: 24492297

Year	Number of Results
1991	3
1993	1
1994	1
1995	2
1997	2
1998	2
1999	4
2000	3
2002	2
2004	1
2005	3
2006	2
2007	3
2008	1
2009	2
2010	3
2011	8
2012	5
2013	8
2014	11
2015	14
2016	7
2017	3
2018	9
2019	11
2020	10
2021	31
2022	43
2023	20
2024	0

1

A new class of bispecific antibodies to redirect T cells for cancer immunotherapy.

Rossi DL, Rossi EA, Cardillo TM, Goldenberg DM, Chang CH. Rossi DL, et al. MAbs. 2014 Mar-Apr;6(2):381-91. doi: 10.4161/mabs.27385. Epub 2013 Dec 2. MAbs. 2014. PMID: 24492297 Free PMC article.

2

A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

Reusch U, Duell J, Ellwanger K, Herbrecht C, Knackmuss SH, Fucek I, Eser M, McAleese F, Molkenthin V, Gall FL, Topp M, Little M, Zhukovsky EA. Reusch U, et al. MAbs. 2015;7(3):584-604. doi: 10.1080/19420862.2015.1029216. MAbs. 2015. PMID: 25875246 Free PMC article.

3

Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells.

Chang CH, Wang Y, Li R, Rossi DL, Liu D, Rossi EA, Cardillo TM, Goldenberg DM. Chang CH, et al. Cancer Res. 2017 Oct 1;77(19):5384-5394. doi: 10.1158/0008-5472.CAN-16-3431. Epub 2017 Aug 17. Cancer Res. 2017. PMID: 28819027

4

Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy.

Kujawski M, Li L, Bhattacharya S, Wong P, Lee WH, Williams L, Li H, Chea J, Poku K, Bowles N, Vaidehi N, Yazaki P, Shively JE. Kujawski M, et al. BMC Cancer. 2019 Sep 5;19(1):882. doi: 10.1186/s12885-019-6056-8. BMC Cancer. 2019. PMID: 31488104 Free PMC article.

5

Redirected T-cell killing of solid cancers targeted with an anti-CD3/Trop-2-bispecific antibody is enhanced in combination with interferon-α.

Rossi EA, Rossi DL, Cardillo TM, Chang CH, Goldenberg DM. Rossi EA, et al. Mol Cancer Ther. 2014 Oct;13(10):2341-51. doi: 10.1158/1535-7163.MCT-14-0345. Epub 2014 Jul 22. Mol Cancer Ther. 2014. PMID: 25053819

6

A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.

Iizuka A, Nonomura C, Ashizawa T, Kondou R, Ohshima K, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Akiyama Y. Iizuka A, et al. Clin Cancer Res. 2019 May 1;25(9):2925-2934. doi: 10.1158/1078-0432.CCR-17-3123. Epub 2019 Feb 8. Clin Cancer Res. 2019. PMID: 30737243

7

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.

Caracciolo D, Riillo C, Ballerini A, Gaipa G, Lhermitte L, Rossi M, Botta C, Duroyon E, Grillone K, Gallo Cantafio ME, Buracchi C, Alampi G, Gulino A, Belmonte B, Conforti F, Golino G, Juli G, Altomare E, Polerà N, Scionti F, Arbitrio M, Iannone M, Martino M, Correale P, Talarico G, Ghelli Luserna di Rorà A, Ferrari A, Concolino D, Sestito S, Pensabene L, Giordano A, Hildinger M, Di Martino MT, Martinelli G, Tripodo C, Asnafi V, Biondi A, Tagliaferri P, Tassone P. Caracciolo D, et al. J Immunother Cancer. 2021 Feb;9(2):e002026. doi: 10.1136/jitc-2020-002026. J Immunother Cancer. 2021. PMID: 33597219 Free PMC article.

8

CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.

Oberst MD, Fuhrmann S, Mulgrew K, Amann M, Cheng L, Lutterbuese P, Richman L, Coats S, Baeuerle PA, Hammond SA. Oberst MD, et al. MAbs. 2014;6(6):1571-84. doi: 10.4161/19420862.2014.975660. MAbs. 2014. PMID: 25484061 Free PMC article.

9

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms.

Link BK, Kostelny SA, Cole MS, Fusselman WP, Tso JY, Weiner GJ. Link BK, et al. Int J Cancer. 1998 Jul 17;77(2):251-6. doi: 10.1002/(sici)1097-0215(19980717)77:2<251::aid-ijc14>3.0.co;2-e. Int J Cancer. 1998. PMID: 9650561 Free article.

10

Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.

Cheng M, Ahmed M, Xu H, Cheung NK. Cheng M, et al. Int J Cancer. 2015 Jan 15;136(2):476-86. doi: 10.1002/ijc.29007. Epub 2014 Jun 19. Int J Cancer. 2015. PMID: 24895182 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

193 results

Results by year